N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression
Open Access
- 1 October 1999
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 274 (44), 31740-31749
- https://doi.org/10.1074/jbc.274.44.31740
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- The NF-κB and IκB System in Injured ArteriesPathobiology, 1998
- β2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblastsKidney International, 1998
- Immunohistochemical study of advanced glycation end products in aging and Alzheimer's disease brainNeuroscience Letters, 1996
- Advanced glycation endproducts (AGEs) induce oxidant stress in the gingiva: a potential mechanism underlying accelerated periodontal disease associated with diabetesJournal of Periodontal Research, 1996
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996
- Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation endproduct-modified serum albuminsProtein Journal, 1995
- Immunological Evidence for the Presence of Advanced Glycosylation End Products in Atherosclerotic Lesions of Euglycemic RabbitsArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rabbits.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988
- Sorbitol, Phosphoinositides, and Sodium-Potassium-ATPase in the Pathogenesis of Diabetic ComplicationsNew England Journal of Medicine, 1987